Thanks for making an appointment
Date and time
2Choose a doctor
3Make an appointment
Date and time
2Choose a doctor
3Make an appointment
The composition of the delegation:
Nicola Simone Seguy, WHO ERO HIV and viral hepatitis medical specialist
Marcelo Naviera-WHO consultant on viral hepatitis control
Sandra Dudareva-senior epidemiologist at the Robert Koch Institute
The purpose of the visit was to discuss the COVIMPACT project on viral hepatitis.
The delegation visited the RMI of Shaykhantakhur district to see the UHEP experience in screening the population for viral hepatitis B and C. During the visit, the delegation was shown the stages of screening. They were acquainted with the unified database and the work. The patient is explained how the screening will take place. The patient is registered in the system by entering passport data, including the screening region, clinic number, passport number and series, last name, first name, patronymic, date of birth, sex, place of birth, and region of residence. After registering, the patient goes to the rapid diagnostic center, where the nurses enter the passport number, once again verify all the passport data, enter the patient's telephone number, and explain to the patient how the screening will take place and why the patient needs it. Then the patient is given an express test for viral hepatitis B and C. The results are recorded in the system. About 246 thousand people were tested under UHEP. The patient goes to the office to be registered.
Then the delegation went to the Research Institute of Virology, where they had a meeting with Director of the Research Institute of Virology, Professor E.I. Musabaev. During the meeting the Director of the Research Institute of Virology E.I. Musabaev told about the Research Institute of Virology, its structure, scientific and international activities, reference laboratory, the structure and work of the clinic.
With the staff of the Research Institute of Virology they discussed screening for viral hepatitis, confirmatory PCR testing, antiviral therapy administered to patients in Uzbekistan.
Also, the new Presidential Resolution № 243 of 16 May 2022, which reflects the creation of a single register of patients with viral hepatitis, the integration of the electronic registry of data, educational work with the population, increasing the screening of the population for viral hepatitis, PCR testing of patients, treatment of patients with chronic viral hepatitis, vaccination against viral hepatitis B, was discussed. In addition, issues of diagnosis of hepatocellular carcinoma among patients with chronic viral hepatitis were discussed. We discussed the future of the project and outlined the main areas of interest for both sides.
